Study may point way forward for bevirimat.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*; D014315:Triterpenes / Q000008:administration & dosage / Q000627:therapeutic use*; D019562:Viral Load; D053978:Pentacyclic Triterpenes
D019380:Anti-HIV Agents; D013386:Succinates; D014315:Triterpenes; C479935:bevirimat; D053978:Pentacyclic Triterpenes